Velcalcetide
Back to searchMolecule Structure
Scientific Name
Velcalcetide
Description of the Drug
Etelcalcetide is a calcium sensing receptor agonist used to treat secondary hyperparathyroidism in patients with chronic kidney disease who require hemodialysis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12865
http://www.drugbank.ca/drugs/DB12865
Brand Name(s)
Parsabiv
Company Owner(s)
Kai Pharmaceuticals Inc A Wholly Owned Subsidiary Of Amgen Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Calcium sensing receptor | SINGLE PROTEIN | AGONIST | CHEMBL1878 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL21982605 | |
| DrugBank | DB12865 | |
| PubChem: Thomson Pharma | 163501454 | |
| PubChem | 71511839 | |
| Nikkaji | J3.559.823E | |
| EPA CompTox Dashboard | DTXSID70155132 | |
| DrugCentral | 5181 | |
| rxnorm | PARSABIV | ETELCALCETIDE |
| ChEBI | 134700 |
